Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physiologically Based Dissolution Testing in a Drug Development Process-a Case Study of a Successful Application in a Bioequivalence Study of Trazodone ER Formulations Under Fed Conditions.
Danielak D, Milanowski B, Wentowski K, Nogowska M, Kątny M, Rogowski P, Konwicki Ł, Puk E, Pieczuro J, Bawiec M, Garbacz G, Lulek J. Danielak D, et al. AAPS PharmSciTech. 2020 Jun 2;21(5):161. doi: 10.1208/s12249-020-01662-8. AAPS PharmSciTech. 2020. PMID: 32488427 Free PMC article.
Impact of genetic variants of selected cytochrome P450 isoenzymes on pharmacokinetics and pharmacodynamics of clopidogrel in patients co-treated with atorvastatin or rosuvastatin.
Karaźniewicz-Łada M, Krzyżańska D, Danielak D, Rzeźniczak J, Główka F, Słomczyński M, Burchardt P. Karaźniewicz-Łada M, et al. Among authors: danielak d. Eur J Clin Pharmacol. 2020 Mar;76(3):419-430. doi: 10.1007/s00228-019-02822-x. Epub 2020 Jan 2. Eur J Clin Pharmacol. 2020. PMID: 31897532
An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics - A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients.
Romański M, Giebułtowicz J, Gniazdowska E, Piotrowski R, Żuk A, Kułakowski P, Paszkowska J, Myslitska D, Sczodrok J, Garbacz G, Danielak D. Romański M, et al. Among authors: danielak d. Int J Pharm. 2024 Jan 5;649:123626. doi: 10.1016/j.ijpharm.2023.123626. Epub 2023 Nov 23. Int J Pharm. 2024. PMID: 38000647
34 results